Bellaire at Stone Port was inspected 27 times between July 23, 2021 and May 5, 2026 by the Virginia Department of Social Services. 17 of those visits ended with violations cited and 10 with none. Across that history VDSS cited 42 violations under 28 distinct standards. 11 inspections were prompted by a complaint.
A violation is a licensing standard - a rule in the Virginia Administrative Code - that the inspector found the facility was not meeting. Each is shown with the evidence the inspector recorded and, where VDSS publishes it, the facility's own plan of correction.
VDSS publishes inspections on a rolling window. 26 of these 27 are still on the state's site; the other 1 has since dropped off it and is reproduced from Assisted Living Magazine's archive of the original VDSS reports.
Provider Information
Inspection History
27Select an inspection to read the areas reviewed, the inspector's comments and any violations cited.
May 5, 2026Complaint survey
- On 05/05/2026 during a tour of the facility, LI observed an unlocked laptop computer with residents’ electronic medical records left unattended on a medication cart in the hallway.
- During an interview with licensing staff on 05/05/2026, staff 1 acknowledged the residents’ information was left unattended and therefore not treated confidentially as required.
- Photo evidence taken.
- On 05/06/2026 while reviewing resident Medication Administration Records (MAR) from April and May 2026, LI observed missed medication administrations for residents 4, 6, and 7.
- MAR for resident 4 indicated Tresiba flex 200 un/ml inject 14 units subcutaneously once daily in the evening, Novolog 100 unit/ml flex pen inject subcutaneously per scale with meals : BS less than 100: 0 units, 100-150: 8 units, 151-200: 10 units, 201 or higher: 12 units, and freestyle libre 3 sensor were not checked/administered on April 24, 2026 at 17:00 med pass. Progress notes for resident 4 indicated that “new LPN passed meds until 1700. He went into resident’s room at 16:40 and it was too early to check BS and give insulin (per resident’s wife) she asked him to come back around 1715. He left without checking BS or giving insulin.” Failure to follow the physician’s order resulted in a total of 1 missed administration of Tresiba and Novolog during the evening medication pass.
- MAR for resident 6 indicated escitalopram 20 mg tablet was not given on 04/04/2026, 04/06/2026, or 04/07/2026 at 9:00 a.m. due to med not found in cart/waiting for pharmacy delivery. Scheduled clonazepam 0.5 mg tablet for 21:00 was not available on 04/10/2026, 04/11/2026, and 04/12/2026, therefore MAR indicates that PRN was given. Ammonium lactate 12% cream was not available due to waiting on pharmacy delivery on 04/15/2026 at 9:00 and 21:00. Cephalexin 500 mg capsule was not available on 04/23/2026 at 21:00 due to waiting on pharmacy delivery. Methylprednisolone 4 mg dose pack for resident 6 beginning 04/24/2026 and ending 04/29/2026 was entered incorrectly on the MAR. Failure to follow the physician’s order resulted in a total of 3 missed administrations of escitalopram during the morning medication pass, 2 missed administrations of ammonia lactate 12% cream one during morning and one during evening medication pass, and 1 missed administration of cephalexin during evening medication pass.
- MAR for resident 7 indicated Advair HFA 115-21 mcg inhaler was not given on 04/22/2026 at 9:00 a.m. and 9:00 p.m. due to waiting on pharmacy delivery. Failure to follow the physician’s order resulted in a total of 2 missed administrations of Advair one during the morning and one during the evening medication pass.
- During an interview on 05/05/2026, licensing inspector (LI) asked for a copy of the updated written agreement, which reflected a change in management company effective 11/01/2025 from Park Street to Gardant Management Solutions.
- Staff 1 confirmed that, at the time of inspection on 05/05/2026, an updated written agreement had not been prepared and provided to the residents and residents’ legal representatives as required by the standard.
- During a tour of the facility on 05/05/2026, LI observed empty menu boards on the special care unit.
- LI observed a small paper menu, which was kept on the counter in the kitchen area, not accessible to residents.
- During an interview with LI on 05/05/2026, staff 1 acknowledged the facility failed to have the menu posted on the day of inspection as required by the standard.
- Photo evidence taken.
- On page 6 of Bellaire at Stone Port’s Medication Management plan, it specifies that, “Each month, a nurse/medication aide will perform an audit to ensure that current medication orders in electronic record match the medications delivered as well as ensuring that scheduled medications are available”.
- On 05/05/2026 while reviewing resident Medication Administration Record (MAR) from April and May 2026, LI observed missed medication administrations for residents 6 and 7, due to medications not being available.
- MAR for resident 6 indicated escitalopram 20 mg tablet was not given on 04/04/2026, 04/06/2026, or 04/07/2026 at 9:00 a.m. due to med not found in cart/waiting for pharmacy delivery. Scheduled clonazepam 0.5 mg tablet for 21:00 was not available on 04/10/2026, 04/11/2026, and 04/12/2026, therefore MAR indicates that PRN was given. Ammonium lactate 12% cream was not available due to waiting on pharmacy delivery on 04/15/2026 at 9:00 and 21:00. Cephalexin 500 mg capsule was not available on 04/23/2026 at 21:00 due to waiting on pharmacy delivery.
- MAR for resident 7 indicated Advair HFA 115-21 mcg inhaler was not given on 04/22/2026 at 9:00 a.m. and 9:00 p.m. due to waiting on pharmacy delivery.
- During an interview on 05/05/2026, licensing inspector (LI) asked for a copy of the updated statement, which reflected a change in management company effective 11/01/2025 from Park Street to Gardant Management Solutions.
- Staff 1 confirmed that an updated statement had not been prepared and provided to the residents and resident’s legal representatives as required by the standard.
- During a facility tour on 05/05/2026, LI observed 2 cleaning carts left unlocked and unattended in the assisted living hallways. Both carts contained chemicals, including acid restroom cleaner, disinfectant, and OdoBan deodorizer/disinfectant.
- During an interview with LI on 05/05/2026, staff 1 acknowledged that the cleaning carts containing the chemicals were unlocked.
- Photo evidence taken.
- LI requested a copy of the facilities written Staffing Plan.
- On 05/05/2026, staff 1 provided the LI with a page from the disclosure statement which provides a general breakdown of staff by shift.
- When asked if the facility had a written staffing plan based on acuity levels and the individualized care needs of the residents in care, staff 1 stated they did not and could only provide the information from the disclosure statement.
May 5, 2026Inspection
- MAR for resident 1 indicated for liothyronine sodium 25 mcg take one tablet by mouth every day beginning 03/27/2026 and ending on 04/07/2026. According to the MAR, first dose of liothyronine sodium 25 mcg was administered on 03/31/2026 at 8:00 a.m.
- Page 5 of the Bellaire at Stone Port Medication Management Plan indicated that “a copy of the order/prescription should be flagged in the resident chart while awaiting medication to arrive from pharmacy. When the medication arrives, the container label should be compared with the physician’s order/prescription for accuracy.
- Staff 1 confirmed by email on 04/27/2026 that the procedure for approving pending medications was for staff to compare the new order in the EMAR to the physician’s order first, which did not occur in this case.
- During review of resident record review, LI observed that liothyronine sodium 25 mcg take one tablet every day beginning 03/27/2026 was listed the MAR for resident 1.
- There was no corresponding physician order in resident 1’s record for liothyronine sodium 25 mcg.
- During an interview on 05/05/2026, staff 1 confirmed there was not a physician’s order for resident 1 for liothyronine sodium 25 mcg.
- A self-reported incident was received by licensing which indicated that a pending order for liothyronine sodium 25 mcg tablet was received through the electronic medication administration record (EMAR) for resident 1 on 03/30/2026, which was approved by Bellaire staff. Self-report stated that this order was entered incorrectly by Family Care Pharmacy and was intended for a resident outside of the community. Error caused resident 1 to receive liothyronine sodium 25 mcg tablet incorrectly for eight days.
- Review of the MAR confirmed that resident 1, admit date 06/18/2024, received liothyronine sodium 25 mcg for a total of eight days beginning on 03/27/2026 through 04/07/2026.
- Per incident report from facility, the pharmacist listed possible side effects of liothyronine sodium which included headache, anxiety, increased appetite, feeling hot, and insomnia. Per incident report, Hospice nurse noted increased anxiety in resident 1 on 03/31/2026 and 04/03/2026, since starting liothyronine sodium 25 mcg.
- Hospice documentation dated 03/31/2026 noted patient attributed the anxiety to staff “not giving her medication correctly”.
October 8, 2025Complaint survey
August 21, 2025Inspection
- During a tour of the facility on 8/21/2025, licensing inspectors were approached by resident 4. Resident 4 appeared agitated and stated “I can’t get my stuff all the doors are locked” referring to the memory care neighborhood. Licensing inspectors checked all the doors and found them locked.
- Staff 6 confirmed that “all doors are locked because we have two residents that go in and take things”.
- Staff 7, 8, and 9 acknowledged that doors in memory care were locked. Corporate had been contacted as facility staff are unable to disable the autolocking feature when the doors close.
- taken.
- Record review for resident 3, admitted 7/18/2025, had a physical examination and report that did not include the physician’s signature.
- During an interview with staff 9 when asked if there was a physical examination and report signed by the physician, staff 9 acknowledged there was not a signed copy.
- During a record review on 8/21/2025, the Licensing Inspector (LI) observed that fire drills were conducted 8/20/2024 on first shift, 9/25/2024 on second shift, 10/13/2024 on first shift, 11/22/2024 on first shift and 12/11/2024 on second shift. No fire drills were completed during third shift from August 2024 through December 2024.
- Staff 7 confirmed that fire drills were not completed on third shift from August 2024 through December 2024.
August 21, 2025Inspection
- The regional licensing office received a self reported incident on 8/5/2025 indicating that on 8/4/2025 staff 2 had administered 100 mg of gabapentin to resident 1 at 8 p.m. instead of the scheduled 300 mg dose of gabapentin.
- Review of the physician’s order for resident 1 indicated one gabapentin 100 mg take capsule by mouth every day at 1 p.m. and one gabapentin 300 mg capsule by mouth daily at 8 p.m.
- Resident 1 had a controlled drug record sheet for gabapentin, indicating to take one 100 mg take capsule by mouth daily at 1 p.m. The sheet had documented administration of 1 tablet by staff 2 on 8/4/2025 at 12:54 p.m. and again on 8/4/2025 at 7:24 p.m.
- Resident 1 had a controlled drug record sheet for gabapentin, indicating to take one 300 mg take capsule by mouth daily at 8 p.m. The sheet had no documented administration of 1 tablet by staff 2 on 8/4/2025.
- During an interview with staff 1 when asked what had occurred during the medication administration on 8/4/2025, staff 1 stated that based on the information, gabapentin 100 mg was administered to resident 1 by staff 2 on 8/4/2025 at 7:24 p.m. as opposed to the physician ordered 300 mg gabapentin.
August 21, 2025Inspection
- The regional licensing office received a self-reported incident on 8/5/2025 indicating that on 8/4/2025 staff 2 had administered one 32.4 mg tablet of phenobarbital to resident 1 at 8:33 p.m. and 10:00 p.m. instead of the scheduled two doses of phenobarbital at 9:00 p.m.
- Review of the physician’s order for resident 1 indicated take one phenobarbital 32.4 mg tablet by mouth every day at 2 p.m. and take two phenobarbital 32.4 mg tablets by mouth daily at 9 p.m. for seizures.
- Resident 1 had a controlled drug record sheet for phenobarbital, indicating to take one 32.4 mg tablet by mouth daily at 2 p.m. The sheet had documented administration of 1 tablet by staff 3 on 8/4/2025 at 1:51 p.m. Staff 2 documented administration of 1 tablet by on 8/4/2025 at 8:33 p.m. and again on 8/4/2025 at 10:00 p.m.
- Resident 1 had a controlled drug record sheet for phenobarbital, indicating to take two 32.4 mg take tablets by mouth daily at bedtime (9 p.m.). The sheet had no documented administration of 2 tablets by staff 2 on 8/4/2025.
- During an interview with staff 1 when asked what had occurred during the medication administration on 8/4/2025, staff 1 stated that based on the information, phenobarbital 32.4 mg was administered to resident 1 by staff 2 on 8/4/2025 at 8:33 p.m. and 10:00 p.m. as opposed to the physician ordered two tablets of phenobarbital 32.4 mg tablets at 9:00 p.m.
August 5, 2025Inspection
- The regional licensing office received a self reported incident on 7/28/2025 indicating that on 7/26/2025 staff 4 and staff 5 reported that the controlled drug record sheet for the Oxycodone was under the correct count of medications in the medication cart and the Lorazepam was over the correct count of medications in the medication cart. The report stated that the Oxycodone was given on 7/26/2025 at 3:23 p.m. in place of the scheduled Lorazepam.
- Review of the Medication Administration Record (MAR) for resident 1 indicated oxycodone one 5 mg tablet by mouth twice daily at 8:00 a.m. and 8:00 p.m.
- Resident 1 had a controlled drug record sheet for oxycodone, indicating to take one 5 mg tablet by mouth twice daily at 8:00 a.m. and 8:00 p.m. The sheet had documented administration of 1 tablet by staff 4 on 7/26/2025 at 7:10 a.m., 3:21 p.m., and 10:05 p.m. Indicating the oxycodone was administered at 3:21 p.m. without a physician's order.
- Review of the MAR for resident 1 indicated lorazepam 0.5 mg one half tablet (0.25) by mouth twice a day at 11:00 a.m. and 4:00 p.m.
- Resident 1 had a controlled drug record sheet for lorazepam 0.5 mg one half tablet (0.25 mg) by mouth twice a day at 11:00 a.m. and 4:00 p.m. Administration documented on 7/26/2025 by staff 4 included only 1 dose of 0.25mg at 10:09 a.m., the controlled substance record sheet did not include administration of lorazepam 0.25 mg at 4:00 p.m.
- During an interview with staff 1 when asked what had occurred during the medication administration on 7/26/2025, staff 1 stated that based on the information found during the facility investigation it was believed that the oxycodone was administered to resident 1 on 7/26/2025 at 3:21 p.m. as opposed to the ordered lorazepam, due to the count of lorazepam being 28 with 29 tablets remaining in the pill pack, and the count of oxycodone being 49 tablets with 48 in the pill pack and the documentation of oxycodone documented as administered at 3:21 p.m. on the controlled drug record without a physicians order to do so.
- During an interview with staff 2 on 8/5/2025, when asked what staff 4 stated when asked what had occurred with the medications administered on 7/26/2025, staff 2 stated that staff 4 answered, “I don’t know”.
- Further review of resident 1’s controlled drug record sheet for lorazepam 0.5 mg one half tablet (0.25) by mouth twice a day at 11:00 a.m. and 4:00 p.m. had documented administration of only one-half tablet (0.25) administered as opposed to the ordered two doses on the following dates; 7/6/2025 at 10:30 a.m., 7/11/2025, time of dosage was not documented, 7/18/2025 at 3:08 p.m., and 7/26/2025 at 10:09 a.m.
- The controlled drug record sheet for resident 1’s ordered lorazepam 0.5 mg one half tablet (0.25) by mouth twice a day at 11:00 a.m. and 4:00 p.m. did not include documentation of the administration of the ordered 0.25 mg half-tablet on 7/6/2025 at 4:00 p.m., 7/11/2025 second dose time unknown, 7/18/2025 at 11:00 a.m., and 7/26/2025 at 4:00 p.m.
- During an interview with staff 1 and staff 3 on 8/13/2025, when reviewing the controlled drug record for the missed doses of lorazepam on 7/6/2025, 7/11/2025, 7/18/2025, and 7/26/2025, staff 3 stated that they were unaware that they were missed.
- Resident 1 had a scheduled order for lorazepam 0.5 mg one half tablet (0.25) by mouth at 11:00 a.m. and 4:00 p.m. Resident 1 had an as needed (PRN) order for lorazepam to take 0.25 mg tablet by mouth every four hours as needed for anxiety.
- MAR for resident 1 dated July 2025 indicated that no PRN lorazepam was received by resident 1. PRN controlled med count sheet for lorazepam indicated 16 doses of PRN lorazepam were administered to resident 1.
- During interview, staff 1 and staff 3 confirmed the PRN lorazepam medication card was being used instead of the scheduled lorazepam medication card.
- Staff 1 and 3 indicated they were unaware staff had administered from incorrect medication card.
- Staff 3 stated there was “no system” for internal monitoring or periodic oversight. Staff 3 stated “I am only looking at med sheet when on cart or there is a question, which is not very often”.
- Page 2 of the Park Street Medication Management Plan indicated that there would be “quarterly healthcare oversight monitors conformance to medication management plan and includes an audit of the med rooms, med carts, STAT box, medication refrigerators, EMARS, med pass observation, and maintenance of required medication reference materials and advises the Executive Director of any concerns.”
- Staff 3 stated that med carts are audited for expired medications periodically on night shift, but controlled medication sheets and counts are not reviewed during that time.
- Page 7 and 8 of the Park Street Medication Management Plan indicated counts for scheduled II-V medications are to be conducted by a nurse or medication aide from the off going shift and a nurse or medication aide from the oncoming shift. Both must count, sign and date count sheets for verification.
July 11, 2025Inspection
July 11, 2025Complaint survey
August 14, 2024Inspection
- Resident 5, admitted on 6/7/2022, had a written fall risk rating last completed on 1/26/2023 on file.
- Resident 6, admitted on 4/5/2023, had a written fall risk rating last completed on 4/5/2023 on file.
- of this review shall be in the resident’s, his legal representative’s or responsible individual’s or staff person’s written acknowledgement of having been so informed, which shall include the date of the review and shall be filed in the resident’s or staff person’s record. Evidence:
- Resident 2 who was admitted on 2/12/2023 did not have acknowledgement of annual Resident rights review on file.
- Resident 6 who was admitted on 4/5/2023 did not have acknowledgement of annual Resident rights review on file.
- During tour on 8/14/2024, this Licensing Inspector (LI) asked Staff 7 where the activities schedule is posted. Staff 7 showed LI an empty display board and stated, “this is where the activities schedule is normally posted”.
- Resident 3 had a DNR order written on 6/12/2024 and the ISP on file, dated 6/25/2024, indicated the resident’s code status was Full Code.
- Resident 4 had a DNR order written on 4/17/2024 and the ISP on file, dated 4/15/2024, indicated the resident’s code status was Full Code.